UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Hypertrophic scarring and keloids following burn injuries

Author
Gerd G Gauglitz, MMS, MD
Section Editor
Marc G Jeschke, MD, PhD
Deputy Editor
Kathryn A Collins, MD, PhD, FACS

INTRODUCTION

Keloids and hypertrophic scars are aberrations of physiologic wound healing characterized by greater and more sustained extracellular matrix deposition. They may also develop following any insult to the dermis.

The early application of topical therapies is advocated for healed burns in an effort to prevent hypertrophic scarring, particularly for deep burn injuries or those that show signs of delayed healing. The role of pressure garment therapy is less clear.

Keloids and hypertrophic scars affect the patient's quality of life, both physically and psychologically, causing pain, pruritus, and contractures. As such, burn patients should be promptly referred to a surgeon experienced in burn care if the wound fails to begin reepithelialization by two weeks, or at the first sign of hypertrophic scarring.

The evaluation and treatment of keloids and hypertrophic scars that result from burn injury is reviewed here. The initial management of the burn wound is reviewed separately. (See "Overview of the management of the severely burned patient".)

INCIDENCE AND RISK FACTORS

Hypertrophic scars occur in between 30 and 90 percent of patients following burns [1,2].

                            
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 17, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Bloemen MC, van der Veer WM, Ulrich MM, et al. Prevention and curative management of hypertrophic scar formation. Burns 2009; 35:463.
  2. Oosterwijk AM, Mouton LJ, Schouten H, et al. Prevalence of scar contractures after burn: A systematic review. Burns 2017; 43:41.
  3. Deitch EA, Wheelahan TM, Rose MP, et al. Hypertrophic burn scars: analysis of variables. J Trauma 1983; 23:895.
  4. Cubison TC, Pape SA, Parkhouse N. Evidence for the link between healing time and the development of hypertrophic scars (HTS) in paediatric burns due to scald injury. Burns 2006; 32:992.
  5. Berman B, Viera MH, Amini S, et al. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 2008; 19:989.
  6. Lewis WH, Sun KK. Hypertrophic scar: a genetic hypothesis. Burns 1990; 16:176.
  7. Gauglitz GG, Kunte C. [Recommendations for the prevention and therapy of hypertrophic scars and keloids]. Hautarzt 2011; 62:337.
  8. Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1--evaluating the evidence. Dermatol Surg 2014; 40:817.
  9. Gold MH, McGuire M, Mustoe TA, et al. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg 2014; 40:825.
  10. Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17:113.
  11. Peacock EE Jr, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J 1970; 63:755.
  12. MANCINI RE, QUAIFE JV. Histogenesis of experimentally produced keloids. J Invest Dermatol 1962; 38:143.
  13. Muir IF. On the nature of keloid and hypertrophic scars. Br J Plast Surg 1990; 43:61.
  14. Brewin MP, Lister TS. Prevention or treatment of hypertrophic burn scarring: a review of when and how to treat with the pulsed dye laser. Burns 2014; 40:797.
  15. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009; 161:8.
  16. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 2006; 18:396.
  17. Sephel GC, Woodward SC. Repair, regeneration, and fibrosis. In: Rubin's Pathology, 4th ed, Rubin E (Ed), Lippincott, Williams & Wilkins, Baltimore 2001. p.84.
  18. van Zuijlen PP, Angeles AP, Kreis RW, et al. Scar assessment tools: implications for current research. Plast Reconstr Surg 2002; 109:1108.
  19. Fearmonti R, Bond J, Erdmann D, Levinson H. A review of scar scales and scar measuring devices. Eplasty 2010; 10:e43.
  20. Tyack Z, Simons M, Spinks A, Wasiak J. A systematic review of the quality of burn scar rating scales for clinical and research use. Burns 2012; 38:6.
  21. van der Wal MB, Verhaegen PD, Middelkoop E, van Zuijlen PP. A clinimetric overview of scar assessment scales. J Burn Care Res 2012; 33:e79.
  22. Gauglitz GG, Bureik D, Dombrowski Y, et al. Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol 2012; 25:313.
  23. Ardehali B, Nouraei SA, Van Dam H, et al. Objective assessment of keloid scars with three-dimensional imaging: quantifying response to intralesional steroid therapy. Plast Reconstr Surg 2007; 119:556.
  24. Van Loey NE, Van Son MJ. Psychopathology and psychological problems in patients with burn scars: epidemiology and management. Am J Clin Dermatol 2003; 4:245.
  25. Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol 2013; 6:103.
  26. Poetschke J, Schwaiger H, Gauglitz GG. Current and Emerging Options for Documenting Scars and Evaluating Therapeutic Progress. Dermatol Surg 2017; 43 Suppl 1:S25.
  27. Tyack Z, Ziviani J, Kimble R, et al. Measuring the impact of burn scarring on health-related quality of life: Development and preliminary content validation of the Brisbane Burn Scar Impact Profile (BBSIP) for children and adults. Burns 2015; 41:1405.
  28. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297:433.
  29. Poetschke J, Reinholz M, Schwaiger H, et al. DLQI and POSAS Scores in Keloid Patients. Facial Plast Surg 2016; 32:289.
  30. Steinstraesser L, Flak E, Witte B, et al. Pressure garment therapy alone and in combination with silicone for the prevention of hypertrophic scarring: randomized controlled trial with intraindividual comparison. Plast Reconstr Surg 2011; 128:306e.
  31. Nedelec B, Carter A, Forbes L, et al. Practice guidelines for the application of nonsilicone or silicone gels and gel sheets after burn injury. J Burn Care Res 2015; 36:345.
  32. Kuhn MA, Moffit MR, Smith PD, et al. Silicone sheeting decreases fibroblast activity and downregulates TGFbeta2 in hypertrophic scar model. Int J Surg Investig 2001; 2:467.
  33. Musgrave MA, Umraw N, Fish JS, et al. The effect of silicone gel sheets on perfusion of hypertrophic burn scars. J Burn Care Rehabil 2002; 23:208.
  34. Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for burn scars and contractures. Burns Incl Therm Inj 1983; 9:201.
  35. Chang CC, Kuo YF, Chiu HC, et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res 1995; 59:705.
  36. Gilman TH. Silicone sheet for treatment and prevention of hypertrophic scar: a new proposal for the mechanism of efficacy. Wound Repair Regen 2003; 11:235.
  37. van der Wal MB, van Zuijlen PP, van de Ven P, Middelkoop E. Topical silicone gel versus placebo in promoting the maturation of burn scars: a randomized controlled trial. Plast Reconstr Surg 2010; 126:524.
  38. Karagoz H, Yuksel F, Ulkur E, Evinc R. Comparison of efficacy of silicone gel, silicone gel sheeting, and topical onion extract including heparin and allantoin for the treatment of postburn hypertrophic scars. Burns 2009; 35:1097.
  39. Momeni M, Hafezi F, Rahbar H, Karimi H. Effects of silicone gel on burn scars. Burns 2009; 35:70.
  40. Harte D, Gordon J, Shaw M, et al. The use of pressure and silicone in hypertrophic scar management in burns patients: a pilot randomized controlled trial. J Burn Care Res 2009; 30:632.
  41. O'Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2013; :CD003826.
  42. Nast A, Eming S, Fluhr J, et al. German S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids). J Dtsch Dermatol Ges 2012; 10:747.
  43. Chernoff WG, Cramer H, Su-Huang S. The efficacy of topical silicone gel elastomers in the treatment of hypertrophic scars, keloid scars, and post-laser exfoliation erythema. Aesthetic Plast Surg 2007; 31:495.
  44. Beuth J, Hunzelmann N, Van Leendert R, et al. Safety and efficacy of local administration of contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. In Vivo 2006; 20:277.
  45. Maragakis M, Willital GH, Michel G, Görtelmeyer R. Possibilities of scar treatment after thoracic surgery. Drugs Exp Clin Res 1995; 21:199.
  46. Chanprapaph K, Tanrattanakorn S, Wattanakrai P, et al. Effectiveness of onion extract gel on surgical scars in asians. Dermatol Res Pract 2012; 2012:212945.
  47. Jackson BA, Shelton AJ. Pilot study evaluating topical onion extract as treatment for postsurgical scars. Dermatol Surg 1999; 25:267.
  48. Chung VQ, Kelley L, Marra D, Jiang SB. Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study. Dermatol Surg 2006; 32:193.
  49. Renò F, Sabbatini M, Lombardi F, et al. In vitro mechanical compression induces apoptosis and regulates cytokines release in hypertrophic scars. Wound Repair Regen 2003; 11:331.
  50. Baur PS, Larson DL, Stacey TR, et al. Ultrastructural analysis of pressure-treated human hypertrophic scars. J Trauma 1976; 16:958.
  51. Macintyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars--a review of the problems associated with their use. Burns 2006; 32:10.
  52. Anzarut A, Olson J, Singh P, et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 2009; 62:77.
  53. Van den Kerckhove E, Stappaerts K, Fieuws S, et al. The assessment of erythema and thickness on burn related scars during pressure garment therapy as a preventive measure for hypertrophic scarring. Burns 2005; 31:696.
  54. Candy LH, Cecilia LT, Ping ZY. Effect of different pressure magnitudes on hypertrophic scar in a Chinese population. Burns 2010; 36:1234.
  55. Chang P, Laubenthal KN, Lewis RW 2nd, et al. Prospective, randomized study of the efficacy of pressure garment therapy in patients with burns. J Burn Care Rehabil 1995; 16:473.
  56. Engrav LH, Heimbach DM, Rivara FP, et al. 12-Year within-wound study of the effectiveness of custom pressure garment therapy. Burns 2010; 36:975.
  57. Li-Tsang CW, Zheng YP, Lau JC. A randomized clinical trial to study the effect of silicone gel dressing and pressure therapy on posttraumatic hypertrophic scars. J Burn Care Res 2010; 31:448.
  58. Petrie NC, Vranckx JJ, Hoeller D, et al. Gene delivery of PDGF for wound healing therapy. J Tissue Viability 2005; 15:16.
  59. Rogers B, Lineaweaver WC. Skin wound healing and cell-mediated DNA transport. J Long Term Eff Med Implants 2002; 12:125.
  60. Gauglitz GG, Jeschke MG. Combined gene and stem cell therapy for cutaneous wound healing. Mol Pharm 2011; 8:1471.
  61. Finnerty CC, Jeschke MG, Branski LK, et al. Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet 2016; 388:1427.
  62. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg 2008; 206:719.
  63. Ogawa R, Akaishi S, Huang C, et al. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 2011; 78:68.
  64. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006; 32:907.
  65. Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns 2014; 40:583.
  66. Grisolia GA, Danti DA, Santoro S, et al. Injection therapy with triamcinolone hexacetonide in the treatment of burn scars in infancy: results of 44 cases. Burns Incl Therm Inj 1983; 10:131.
  67. Wang XQ, Liu YK, Qing C, Lu SL. A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 2009; 63:688.
  68. Trisliana Perdanasari A, Torresetti M, Grassetti L, et al. Intralesional injection treatment of hypertrophic scars and keloids: a systematic review regarding outcomes. Burns Trauma 2015; 3:14.
  69. Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol 2008; 74:343.
  70. Verhiel S, Piatkowski de Grzymala A, van der Hulst R. Mechanism of Action, Efficacy, and Adverse Events of Calcium Antagonists in Hypertrophic Scars and Keloids: A Systematic Review. Dermatol Surg 2015; 41:1343.
  71. Danielsen PL, Rea SM, Wood FM, et al. Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial. Acta Derm Venereol 2016; 96:774.
  72. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 2009; 34:219.
  73. Davison SP, Dayan JH, Clemens MW, et al. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthet Surg J 2009; 29:40.
  74. Stekelenburg CM, Marck RE, Tuinebreijer WE, et al. A systematic review on burn scar contracture treatment: searching for evidence. J Burn Care Res 2015; 36:e153.
  75. Stekelenburg CM, Jaspers ME, Jongen SJ, et al. Perforator-Based Interposition Flaps Perform Better Than Full-Thickness Grafts for the Release of Burn Scar Contractures: A Multicenter Randomized Controlled Trial. Plast Reconstr Surg 2017; 139:501e.
  76. Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007; 25:26.
  77. Poochareon VN, Berman B. New therapies for the management of keloids. J Craniofac Surg 2003; 14:654.
  78. Patel PA, Bailey JK, Yakuboff KP. Treatment outcomes for keloid scar management in the pediatric burn population. Burns 2012; 38:767.
  79. Stahl S, Barnea Y, Weiss J, et al. Treatment of earlobe keloids by extralesional excision combined with preoperative and postoperative "sandwich" radiotherapy. Plast Reconstr Surg 2010; 125:135.
  80. Stiefel D, Schiestl C, Meuli M. Integra Artificial Skin for burn scar revision in adolescents and children. Burns 2010; 36:114.
  81. Willows BM, Ilyas M, Sharma A. Laser in the management of burn scars. Burns 2017; 43:1379.
  82. Leclère FM, Mordon SR. Twenty-five years of active laser prevention of scars: what have we learned? J Cosmet Laser Ther 2010; 12:227.
  83. Blome-Eberwein S, Gogal C, Weiss MJ, et al. Prospective Evaluation of Fractional CO2 Laser Treatment of Mature Burn Scars. J Burn Care Res 2016; 37:379.
  84. Nouri K, Rivas MP, Stevens M, et al. Comparison of the effectiveness of the pulsed dye laser 585 nm versus 595 nm in the treatment of new surgical scars. Lasers Med Sci 2009; 24:801.
  85. Nouri K, Elsaie ML, Vejjabhinanta V, et al. Comparison of the effects of short- and long-pulse durations when using a 585-nm pulsed dye laser in the treatment of new surgical scars. Lasers Med Sci 2010; 25:121.
  86. Tanzi EL, Alster TS. Laser treatment of scars. Skin Therapy Lett 2004; 9:4.
  87. Alster TS, Handrick C. Laser treatment of hypertrophic scars, keloids, and striae. Semin Cutan Med Surg 2000; 19:287.
  88. Paquet P, Hermanns JF, Piérard GE. Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 2001; 27:171.
  89. Bowes LE, Nouri K, Berman B, et al. Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatol Surg 2002; 28:714.
  90. Akaishi S, Koike S, Dohi T, et al. Nd:YAG Laser Treatment of Keloids and Hypertrophic Scars. Eplasty 2012; 12:e1.
  91. Poetschke J, Dornseifer U, Clementoni MT, et al. Ultrapulsed fractional ablative carbon dioxide laser treatment of hypertrophic burn scars: evaluation of an in-patient controlled, standardized treatment approach. Lasers Med Sci 2017; 32:1031.
  92. Qu L, Liu A, Zhou L, et al. Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med 2012; 44:517.
  93. Ozog DM, Liu A, Chaffins ML, et al. Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser. JAMA Dermatol 2013; 149:50.
  94. Suh DH, Chang, KY, et al. Revision of burn scars using ablative fractional CO2 laser. J Am Acad Dermatol 2012; 66:AB216.
  95. Hultman CS, Friedstat JS, Edkins RE, et al. Laser resurfacing and remodeling of hypertrophic burn scars: the results of a large, prospective, before-after cohort study, with long-term follow-up. Ann Surg 2014; 260:519.
  96. Levi B, Ibrahim A, Mathews K, et al. The Use of CO2 Fractional Photothermolysis for the Treatment of Burn Scars. J Burn Care Res 2016; 37:106.
  97. Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg 2003; 111:1853.
  98. Guix B, Henríquez I, Andrés A, et al. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study. Int J Radiat Oncol Biol Phys 2001; 50:167.
  99. Escarmant P, Zimmermann S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys 1993; 26:245.
  100. Sällström KO, Larson O, Hedén P, et al. Treatment of keloids with surgical excision and postoperative X-ray radiation. Scand J Plast Reconstr Surg Hand Surg 1989; 23:211.
  101. van de Kar AL, Kreulen M, van Zuijlen PP, Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: a prospective clinical outcome study. Plast Reconstr Surg 2007; 119:2248.
  102. Berman B, Harrison-Balestra C, Perez OA, et al. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study. J Drugs Dermatol 2009; 8:455.
  103. Cação FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg 2009; 35:629.
  104. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 2006; 8:362.
  105. Cho YS, Jeon JH, Hong A, et al. The effect of burn rehabilitation massage therapy on hypertrophic scar after burn: a randomized controlled trial. Burns 2014; 40:1513.
  106. Roh YS, Seo CH, Jang KU. Effects of a skin rehabilitation nursing program on skin status, depression, and burn-specific health in burn survivors. Rehabil Nurs 2010; 35:65.
  107. Field T, Peck M, Scd, et al. Postburn itching, pain, and psychological symptoms are reduced with massage therapy. J Burn Care Rehabil 2000; 21:189.
  108. Silverberg R, Johnson J, Moffat M. The effects of soft tissue mobilization on the immature burn scar: results of a pilot study. J Burn Care Rehabil 1996; 17:252.
  109. Ault P, Plaza A, Paratz J. Scar massage for hypertrophic burns scarring-A systematic review. Burns 2017.
  110. Zuber TJ, DeWitt DE. Earlobe keloids. Am Fam Physician 1994; 49:1835.
  111. Hatamipour E, Mehrabi S, Hatamipour M, Ghafarian Shirazi HR. Effects of combined intralesional 5-Fluorouracil and topical silicone in prevention of keloids: a double blind randomized clinical trial study. Acta Med Iran 2011; 49:127.
  112. Hassel JC, Löser C, Koenen W, et al. Promising results from a pilot study on compression treatment of ear keloids. J Cutan Med Surg 2011; 15:130.
  113. Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 2014; 67:1017.
  114. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon 2007; 5:175.
  115. Haurani MJ, Foreman K, Yang JJ, Siddiqui A. 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 2009; 123:139.
  116. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther 2004; 17:212.
  117. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004; 30:54.
  118. http://sunnybrook.ca/content/?page=ross-tilley-burn-centre (Accessed on June 08, 2017).